232 related articles for article (PubMed ID: 22802528)
1. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ
Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528
[TBL] [Abstract][Full Text] [Related]
2. The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence.
Aksoy O; Chicas A; Zeng T; Zhao Z; McCurrach M; Wang X; Lowe SW
Genes Dev; 2012 Jul; 26(14):1546-57. PubMed ID: 22802529
[TBL] [Abstract][Full Text] [Related]
3. DNA-damage response control of E2F7 and E2F8.
Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
[TBL] [Abstract][Full Text] [Related]
4. An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability.
Mitxelena J; Apraiz A; Vallejo-Rodríguez J; García-Santisteban I; Fullaondo A; Alvarez-Fernández M; Malumbres M; Zubiaga AM
Nucleic Acids Res; 2018 May; 46(9):4546-4559. PubMed ID: 29590434
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
[TBL] [Abstract][Full Text] [Related]
6. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.
Liu B; Shats I; Angus SP; Gatza ML; Nevins JR
J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115
[TBL] [Abstract][Full Text] [Related]
7. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
Li J; Ran C; Li E; Gordon F; Comstock G; Siddiqui H; Cleghorn W; Chen HZ; Kornacker K; Liu CG; Pandit SK; Khanizadeh M; Weinstein M; Leone G; de Bruin A
Dev Cell; 2008 Jan; 14(1):62-75. PubMed ID: 18194653
[TBL] [Abstract][Full Text] [Related]
8. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.
Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A
EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738
[TBL] [Abstract][Full Text] [Related]
9. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.
Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A
Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520
[TBL] [Abstract][Full Text] [Related]
10. E2f8 mediates tumor suppression in postnatal liver development.
Kent LN; Rakijas JB; Pandit SK; Westendorp B; Chen HZ; Huntington JT; Tang X; Bae S; Srivastava A; Senapati S; Koivisto C; Martin CK; Cuitino MC; Perez M; Clouse JM; Chokshi V; Shinde N; Kladney R; Sun D; Perez-Castro A; Matondo RB; Nantasanti S; Mokry M; Huang K; Machiraju R; Fernandez S; Rosol TJ; Coppola V; Pohar KS; Pipas JM; Schmidt CR; de Bruin A; Leone G
J Clin Invest; 2016 Aug; 126(8):2955-69. PubMed ID: 27454291
[TBL] [Abstract][Full Text] [Related]
11. Functional interplay between E2F7 and ribosomal rRNA gene transcription regulates protein synthesis.
Coutts AS; Munro S; La Thangue NB
Cell Death Dis; 2018 May; 9(5):577. PubMed ID: 29760477
[TBL] [Abstract][Full Text] [Related]
12. E2F7 drives autotaxin/Enpp2 transcription via chromosome looping: Repression by p53 in murine but not in human carcinomas.
Lin KH; Lee SC; Dacheux MA; Norman DD; Balogh A; Bavaria M; Lee H; Tigyi G
FASEB J; 2023 Jul; 37(7):e23058. PubMed ID: 37358838
[TBL] [Abstract][Full Text] [Related]
13. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression.
Westendorp B; Mokry M; Groot Koerkamp MJ; Holstege FC; Cuppen E; de Bruin A
Nucleic Acids Res; 2012 Apr; 40(8):3511-23. PubMed ID: 22180533
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G
J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818
[TBL] [Abstract][Full Text] [Related]
15. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
[TBL] [Abstract][Full Text] [Related]
16. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.
Di Stefano L; Jensen MR; Helin K
EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988
[TBL] [Abstract][Full Text] [Related]
17. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
18. E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.
Wang Y; Pei X; Xu P; Tan Z; Zhu Z; Zhang G; Jiang Z; Deng Z
Oncol Rep; 2020 Sep; 44(3):849-862. PubMed ID: 32582990
[TBL] [Abstract][Full Text] [Related]
19. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation.
Maiti B; Li J; de Bruin A; Gordon F; Timmers C; Opavsky R; Patil K; Tuttle J; Cleghorn W; Leone G
J Biol Chem; 2005 May; 280(18):18211-20. PubMed ID: 15722552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
